Explore 3 Stock Ideas & Industry Insights Download Free Report

General News

Can Corebridge Financial (NYSE:CRBG), 2.3% Below Its 52-Week High, Hold Gains Until Its Merger Closes?

Corebridge reported adjusted after-tax operating income of USD 512 million, or USD 1.12 per share, in the quarter ended June 30, 2026, per the August 4, 2026 release. GAAP results showed a net loss to common shareholders of USD 16 million, or USD 0.04 …

Vinay Lochav | 16 October 2026

Is Baldwin Insurance Group (NASDAQ:BWIN), 2.3% Below Its 52-Week High, Now a USD 32.50 Buyout Trade?

The stock reached its high because a cash offer replaced fundamental pricing. After a June 2026 report that Baldwin Insurance Group had hired Ardea to explore strategic options, the board approved an all-cash merger on September 14, 2026, unanimously. Completion has no financing condition …

Vinay Lochav | 16 October 2026

Why Is NIQ Global Intelligence (NYSE:NIQ), 3.0% From a 52-Week High, 9.0% Under Its IPO Price?

NIQ reported second quarter revenue of USD 1,124.2 million, up 8.0% reported and 5.8% in organic constant currency, with adjusted EBITDA margin up 270 basis points to 23.3%, per the August 10, 2026 release. Net loss attributable to NIQ was USD 30.5 million, so …

Vinay Lochav | 16 October 2026

Why Is Cigna Group (NYSE:CI) 2.8% Below Its 52-Week High at 9.9 Times Guided EPS?

Cigna Group (NYSE:CI) closed at USD 298.81 on October 15, 2026, up 3.19%, and traded at USD 302.77 intraday on October 16. No company release explains the October 15 move. It followed the October 9 Star Ratings news at Humana (NYSE:HUM). The valuation is …

Vinay Lochav | 16 October 2026

Can Tenet Healthcare (NYSE:THC) Clear Its 52-Week High, 2.7% Away, After a USD 1.04 Billion Buyback?

Tenet Healthcare (NYSE:THC) closed at USD 275.13 on October 15, 2026, up 1.30%, per exchange data. The intraday price of USD 275.38 is 0.09% higher, own arithmetic, with an RSI of 65.8. Published market data show a trailing P/E of 10.68, reflecting GAAP EPS …

Vinay Lochav | 16 October 2026

Can Hinge Health (NYSE:HNGE) Hold 2.5% Below Its 52-Week High With 53% Revenue Growth?

Hinge Health (NYSE:HNGE) is up from a 52-week low of USD 30.08, and its RSI of 67.4 sits below the 70 overbought threshold. Published market data show a trailing P/E of 78.04 and a forward P/E of 40.34. Quotes differ within the session: a …

Vinay Lochav | 16 October 2026

Why Is Haemonetics (NYSE:HAE) 2.5% Below Its 52-Week High After a 16% CSL Plasma Rally?

Haemonetics (NYSE:HAE) has risen 2.5 times from its 52-week low of USD 48.55, own arithmetic. Published market data show a trailing P/E of 58.73 against a forward P/E of 21.95, reflecting the gap between GAAP and adjusted earnings. The catalyst was the CSL Plasma …

Vinay Lochav | 16 October 2026

Can Gilead Sciences (NASDAQ:GILD) Hold 2.6% Below Its 52-Week High After a USD 11.2 Billion Charge?

Gilead Sciences (NASDAQ:GILD) traded at USD 156.38 at 10:18 a.m. ET on October 16, 2026, down 0.63%, inside a 52-week range of USD 114.02 to USD 160.51 per published market data. The RSI of 64.1 is below the 70 overbought threshold, and relative volume …

Vinay Lochav | 16 October 2026

Can Amgen (NASDAQ:AMGN) Break Its USD 447.03 High With Analyst Targets 11% Below the Price?

Amgen (NASDAQ:AMGN) rose 0.47% to USD 436.09 on October 16, 2026 per published market data, with an RSI of 64.9 and relative volume of 0.1x early in the session. The 50-day range was USD 375.65 to USD 444.12. The dividend is USD 2.52 a …

Vinay Lochav | 16 October 2026

Why Is AbbVie (NYSE:ABBV) 2.5% Below Its High Despite a USD 0.11 Per Share IPR&D Hit?

AbbVie (NYSE:ABBV) rose 0.29% to USD 284.21 on October 16, 2026 per published market data, on relative volume of 0.2x early in the session. The shares were USD 260.69 on September 3, 2026, so they are up 9.0% since then (own arithmetic). On the …

Vinay Lochav | 16 October 2026
Support

Hi! How can we help you today?

Loading…